It has also been demonstrated that, using immunohistochemical analysis of melanoma brain metastases, three-quarters of melanoma CNS lesions exhibit tumour-infiltrating T-lymphocytes, and about half have detectable PD-L1 expression on tumour cells. The gene discussed is CD274; the disease is melanoma.